nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ACE—stomach cancer	0.506	1	CbGaD
Lisinopril—ABCB1—Mitomycin—stomach cancer	0.0923	0.581	CbGbCtD
Lisinopril—ACE2—bile—stomach cancer	0.0312	0.352	CbGeAlD
Lisinopril—ABCB1—Irinotecan—stomach cancer	0.0237	0.149	CbGbCtD
Lisinopril—ABCB1—Docetaxel—stomach cancer	0.0173	0.109	CbGbCtD
Lisinopril—ABCB1—Doxorubicin—stomach cancer	0.0129	0.0814	CbGbCtD
Lisinopril—ABCB1—Methotrexate—stomach cancer	0.0125	0.0789	CbGbCtD
Lisinopril—ACE—vein—stomach cancer	0.00949	0.107	CbGeAlD
Lisinopril—ACE2—gall bladder—stomach cancer	0.00867	0.0976	CbGeAlD
Lisinopril—ACE2—hematopoietic system—stomach cancer	0.00491	0.0552	CbGeAlD
Lisinopril—ACE2—ACE Inhibitor Pathway—AGTR2—stomach cancer	0.00479	0.104	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—ACE—stomach cancer	0.0043	0.0932	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—ACE—stomach cancer	0.00409	0.0887	CbGpPWpGaD
Lisinopril—ACE2—digestive system—stomach cancer	0.00341	0.0384	CbGeAlD
Lisinopril—ACE—blood vessel—stomach cancer	0.00301	0.0339	CbGeAlD
Lisinopril—ACE2—endocrine gland—stomach cancer	0.00282	0.0317	CbGeAlD
Lisinopril—ACE2—liver—stomach cancer	0.00254	0.0286	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—CDX2—stomach cancer	0.00218	0.0474	CbGpPWpGaD
Lisinopril—ACE—ACE Inhibitor Pathway—AGTR2—stomach cancer	0.00214	0.0464	CbGpPWpGaD
Lisinopril—SLC15A1—epithelium—stomach cancer	0.00204	0.023	CbGeAlD
Lisinopril—ACE2—lymph node—stomach cancer	0.00195	0.0219	CbGeAlD
Lisinopril—ACE2—ACE Inhibitor Pathway—NOS3—stomach cancer	0.0019	0.0413	CbGpPWpGaD
Lisinopril—ACE—hematopoietic system—stomach cancer	0.0016	0.0181	CbGeAlD
Lisinopril—SLC15A1—digestive system—stomach cancer	0.00156	0.0175	CbGeAlD
Lisinopril—ACE—epithelium—stomach cancer	0.00147	0.0165	CbGeAlD
Lisinopril—ACE—smooth muscle tissue—stomach cancer	0.00141	0.0159	CbGeAlD
Lisinopril—SLC15A1—endocrine gland—stomach cancer	0.00129	0.0145	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—PAX6—stomach cancer	0.00127	0.0276	CbGpPWpGaD
Lisinopril—SLC15A1—liver—stomach cancer	0.00116	0.0131	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—ACE—stomach cancer	0.00113	0.0245	CbGpPWpGaD
Lisinopril—ACE—lymphoid tissue—stomach cancer	0.00113	0.0127	CbGeAlD
Lisinopril—ACE—digestive system—stomach cancer	0.00112	0.0126	CbGeAlD
Lisinopril—ABCB1—blood vessel—stomach cancer	0.00106	0.0119	CbGeAlD
Lisinopril—ACE—bone marrow—stomach cancer	0.00103	0.0116	CbGeAlD
Lisinopril—ACE—Peptide hormone metabolism—CDX2—stomach cancer	0.000975	0.0212	CbGpPWpGaD
Lisinopril—ACE—endocrine gland—stomach cancer	0.000921	0.0104	CbGeAlD
Lisinopril—ACE—ACE Inhibitor Pathway—NOS3—stomach cancer	0.000851	0.0184	CbGpPWpGaD
Lisinopril—ACE—liver—stomach cancer	0.000831	0.00936	CbGeAlD
Lisinopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A2—stomach cancer	0.000816	0.0177	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—NOP56—stomach cancer	0.000785	0.017	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—DPAGT1—stomach cancer	0.000785	0.017	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—EEF1A2—stomach cancer	0.000718	0.0156	CbGpPWpGaD
Lisinopril—Fosinopril—ACE—stomach cancer	0.000698	0.127	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—MUC6—stomach cancer	0.000667	0.0145	CbGpPWpGaD
Lisinopril—ACE—lymph node—stomach cancer	0.000637	0.00717	CbGeAlD
Lisinopril—ACE2—Metabolism of proteins—CCT7—stomach cancer	0.000595	0.0129	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—PAX6—stomach cancer	0.000569	0.0123	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—TUBA1C—stomach cancer	0.000567	0.0123	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—EEF1A1—stomach cancer	0.000567	0.0123	CbGpPWpGaD
Lisinopril—ABCB1—hematopoietic system—stomach cancer	0.000565	0.00636	CbGeAlD
Lisinopril—Spirapril—ACE—stomach cancer	0.000563	0.102	CrCbGaD
Lisinopril—Moexipril—ACE—stomach cancer	0.00054	0.0982	CrCbGaD
Lisinopril—Benazepril—MTHFR—stomach cancer	0.000535	0.0975	CrCbGaD
Lisinopril—ABCB1—epithelium—stomach cancer	0.000516	0.00581	CbGeAlD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—PPP2R4—stomach cancer	0.000512	0.0111	CbGpPWpGaD
Lisinopril—Cilazapril—ACE—stomach cancer	0.000502	0.0913	CrCbGaD
Lisinopril—Quinapril—ACE—stomach cancer	0.000502	0.0913	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—EXOSC5—stomach cancer	0.00049	0.0106	CbGpPWpGaD
Lisinopril—Trandolapril—ACE—stomach cancer	0.000486	0.0885	CrCbGaD
Lisinopril—Ramipril—ACE—stomach cancer	0.000486	0.0885	CrCbGaD
Lisinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—stomach cancer	0.00048	0.0104	CbGpPWpGaD
Lisinopril—ABCB1—pancreas—stomach cancer	0.00046	0.00518	CbGeAlD
Lisinopril—Benazepril—ACE—stomach cancer	0.000437	0.0795	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—CDX2—stomach cancer	0.000412	0.00894	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—RPL18—stomach cancer	0.000404	0.00877	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—RPL13—stomach cancer	0.000404	0.00877	CbGpPWpGaD
Lisinopril—ABCB1—lymphoid tissue—stomach cancer	0.000397	0.00448	CbGeAlD
Lisinopril—ABCB1—digestive system—stomach cancer	0.000393	0.00442	CbGeAlD
Lisinopril—ACE2—Metabolism of proteins—RPS21—stomach cancer	0.000377	0.00818	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—RPS15—stomach cancer	0.000377	0.00818	CbGpPWpGaD
Lisinopril—Enalapril—ACE—stomach cancer	0.000368	0.067	CrCbGaD
Lisinopril—ABCB1—bone marrow—stomach cancer	0.000362	0.00408	CbGeAlD
Lisinopril—ACE2—Metabolism of proteins—MUC2—stomach cancer	0.000351	0.0076	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—DPAGT1—stomach cancer	0.000351	0.0076	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—NOP56—stomach cancer	0.000351	0.0076	CbGpPWpGaD
Lisinopril—ABCB1—endocrine gland—stomach cancer	0.000324	0.00365	CbGeAlD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—BNIP3—stomach cancer	0.000322	0.00698	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—EEF1A2—stomach cancer	0.000321	0.00695	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—RPL15—stomach cancer	0.000306	0.00664	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—HSPD1—stomach cancer	0.000306	0.00664	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—MUC6—stomach cancer	0.000298	0.00646	CbGpPWpGaD
Lisinopril—ABCB1—liver—stomach cancer	0.000292	0.00329	CbGeAlD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.000287	0.00623	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—RPS26—stomach cancer	0.000286	0.0062	CbGpPWpGaD
Lisinopril—Nateglinide—PPARG—stomach cancer	0.000274	0.0499	CrCbGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—PLIN2—stomach cancer	0.00027	0.00585	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CCT7—stomach cancer	0.000266	0.00576	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—IGFBP3—stomach cancer	0.000259	0.00561	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NT5E—stomach cancer	0.000256	0.00554	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—TUBA1C—stomach cancer	0.000253	0.0055	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—EEF1A1—stomach cancer	0.000253	0.0055	CbGpPWpGaD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	0.000253	0.00548	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000251	0.00544	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—RPS19—stomach cancer	0.000243	0.00527	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—PAX6—stomach cancer	0.00024	0.00521	CbGpPWpGaD
Lisinopril—ABCB1—lymph node—stomach cancer	0.000224	0.00253	CbGeAlD
Lisinopril—ACE—Metabolism of proteins—EXOSC5—stomach cancer	0.000219	0.00474	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—RPS6—stomach cancer	0.000215	0.00466	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000215	0.00466	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ACE—stomach cancer	0.000213	0.00462	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYT1—stomach cancer	0.00019	0.00413	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—RORA—stomach cancer	0.000189	0.0041	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CDX2—stomach cancer	0.000184	0.00399	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—RPL13—stomach cancer	0.000181	0.00392	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—RPL18—stomach cancer	0.000181	0.00392	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NPM1—stomach cancer	0.000171	0.0037	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—RPS21—stomach cancer	0.000168	0.00365	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—RPS15—stomach cancer	0.000168	0.00365	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—stomach cancer	0.000159	0.00345	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—MUC2—stomach cancer	0.000157	0.0034	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—stomach cancer	0.000138	0.00298	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—RPL15—stomach cancer	0.000137	0.00297	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—HSPD1—stomach cancer	0.000137	0.00297	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—ENO1—stomach cancer	0.000134	0.00291	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—RPS26—stomach cancer	0.000128	0.00277	CbGpPWpGaD
Lisinopril—ABCB1—ABC-family proteins mediated transport—APOA1—stomach cancer	0.000121	0.00262	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—IGFBP3—stomach cancer	0.000116	0.00251	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000111	0.00241	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000109	0.00237	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—RPS19—stomach cancer	0.000109	0.00235	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—PAX6—stomach cancer	0.000107	0.00233	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—MMP2—stomach cancer	0.000106	0.0023	CbGpPWpGaD
Lisinopril—Nateglinide—ALB—stomach cancer	0.000103	0.0188	CrCbGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—HMOX1—stomach cancer	9.8e-05	0.00212	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—RPS6—stomach cancer	9.6e-05	0.00208	CbGpPWpGaD
Lisinopril—Dyspnoea—Docetaxel—stomach cancer	9.42e-05	0.000483	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—SMAD4—stomach cancer	9.4e-05	0.00204	CbGpPWpGaD
Lisinopril—Somnolence—Docetaxel—stomach cancer	9.39e-05	0.000482	CcSEcCtD
Lisinopril—Mental disorder—Methotrexate—stomach cancer	9.39e-05	0.000482	CcSEcCtD
Lisinopril—Tinnitus—Epirubicin—stomach cancer	9.35e-05	0.00048	CcSEcCtD
Lisinopril—Erythema—Methotrexate—stomach cancer	9.33e-05	0.000478	CcSEcCtD
Lisinopril—Malnutrition—Methotrexate—stomach cancer	9.33e-05	0.000478	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Capecitabine—stomach cancer	9.32e-05	0.000478	CcSEcCtD
Lisinopril—Flushing—Epirubicin—stomach cancer	9.31e-05	0.000477	CcSEcCtD
Lisinopril—Vomiting—Fluorouracil—stomach cancer	9.31e-05	0.000477	CcSEcCtD
Lisinopril—Rhinitis—Doxorubicin—stomach cancer	9.3e-05	0.000477	CcSEcCtD
Lisinopril—Dyspepsia—Docetaxel—stomach cancer	9.3e-05	0.000477	CcSEcCtD
Lisinopril—Hepatitis—Doxorubicin—stomach cancer	9.28e-05	0.000476	CcSEcCtD
Lisinopril—Insomnia—Capecitabine—stomach cancer	9.25e-05	0.000474	CcSEcCtD
Lisinopril—Rash—Fluorouracil—stomach cancer	9.23e-05	0.000473	CcSEcCtD
Lisinopril—Dermatitis—Fluorouracil—stomach cancer	9.22e-05	0.000473	CcSEcCtD
Lisinopril—Pharyngitis—Doxorubicin—stomach cancer	9.21e-05	0.000472	CcSEcCtD
Lisinopril—Paraesthesia—Capecitabine—stomach cancer	9.19e-05	0.000471	CcSEcCtD
Lisinopril—Decreased appetite—Docetaxel—stomach cancer	9.18e-05	0.000471	CcSEcCtD
Lisinopril—Headache—Fluorouracil—stomach cancer	9.17e-05	0.00047	CcSEcCtD
Lisinopril—Urinary tract disorder—Doxorubicin—stomach cancer	9.17e-05	0.00047	CcSEcCtD
Lisinopril—Oedema peripheral—Doxorubicin—stomach cancer	9.14e-05	0.000469	CcSEcCtD
Lisinopril—Dysgeusia—Methotrexate—stomach cancer	9.14e-05	0.000469	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Docetaxel—stomach cancer	9.12e-05	0.000468	CcSEcCtD
Lisinopril—Dyspnoea—Capecitabine—stomach cancer	9.12e-05	0.000468	CcSEcCtD
Lisinopril—Fatigue—Docetaxel—stomach cancer	9.11e-05	0.000467	CcSEcCtD
Lisinopril—Angiopathy—Epirubicin—stomach cancer	9.1e-05	0.000467	CcSEcCtD
Lisinopril—Urethral disorder—Doxorubicin—stomach cancer	9.1e-05	0.000467	CcSEcCtD
Lisinopril—Nausea—Irinotecan—stomach cancer	9.08e-05	0.000466	CcSEcCtD
Lisinopril—Mediastinal disorder—Epirubicin—stomach cancer	9.04e-05	0.000464	CcSEcCtD
Lisinopril—Pain—Docetaxel—stomach cancer	9.04e-05	0.000463	CcSEcCtD
Lisinopril—Constipation—Docetaxel—stomach cancer	9.04e-05	0.000463	CcSEcCtD
Lisinopril—Back pain—Methotrexate—stomach cancer	9.03e-05	0.000463	CcSEcCtD
Lisinopril—Dyspepsia—Capecitabine—stomach cancer	9e-05	0.000462	CcSEcCtD
Lisinopril—Chills—Epirubicin—stomach cancer	9e-05	0.000462	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BID—stomach cancer	9e-05	0.00195	CbGpPWpGaD
Lisinopril—Arrhythmia—Epirubicin—stomach cancer	8.96e-05	0.00046	CcSEcCtD
Lisinopril—Decreased appetite—Capecitabine—stomach cancer	8.89e-05	0.000456	CcSEcCtD
Lisinopril—Alopecia—Epirubicin—stomach cancer	8.86e-05	0.000455	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Capecitabine—stomach cancer	8.83e-05	0.000453	CcSEcCtD
Lisinopril—Fatigue—Capecitabine—stomach cancer	8.82e-05	0.000452	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—CXCL8—stomach cancer	8.8e-05	0.00191	CbGpPWpGaD
Lisinopril—Vision blurred—Methotrexate—stomach cancer	8.79e-05	0.000451	CcSEcCtD
Lisinopril—Mental disorder—Epirubicin—stomach cancer	8.79e-05	0.000451	CcSEcCtD
Lisinopril—Erythema multiforme—Doxorubicin—stomach cancer	8.78e-05	0.00045	CcSEcCtD
Lisinopril—Constipation—Capecitabine—stomach cancer	8.75e-05	0.000449	CcSEcCtD
Lisinopril—Pain—Capecitabine—stomach cancer	8.75e-05	0.000449	CcSEcCtD
Lisinopril—Malnutrition—Epirubicin—stomach cancer	8.73e-05	0.000448	CcSEcCtD
Lisinopril—Erythema—Epirubicin—stomach cancer	8.73e-05	0.000448	CcSEcCtD
Lisinopril—Feeling abnormal—Docetaxel—stomach cancer	8.71e-05	0.000446	CcSEcCtD
Lisinopril—Nausea—Fluorouracil—stomach cancer	8.7e-05	0.000446	CcSEcCtD
Lisinopril—Ill-defined disorder—Methotrexate—stomach cancer	8.66e-05	0.000444	CcSEcCtD
Lisinopril—Tinnitus—Doxorubicin—stomach cancer	8.65e-05	0.000444	CcSEcCtD
Lisinopril—Gastrointestinal pain—Docetaxel—stomach cancer	8.64e-05	0.000443	CcSEcCtD
Lisinopril—Anaemia—Methotrexate—stomach cancer	8.62e-05	0.000442	CcSEcCtD
Lisinopril—Flushing—Doxorubicin—stomach cancer	8.61e-05	0.000442	CcSEcCtD
Lisinopril—Flatulence—Epirubicin—stomach cancer	8.6e-05	0.000441	CcSEcCtD
Lisinopril—Tension—Epirubicin—stomach cancer	8.57e-05	0.000439	CcSEcCtD
Lisinopril—Dysgeusia—Epirubicin—stomach cancer	8.55e-05	0.000438	CcSEcCtD
Lisinopril—Nervousness—Epirubicin—stomach cancer	8.48e-05	0.000435	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—CLCN3—stomach cancer	8.47e-05	0.00184	CbGpPWpGaD
Lisinopril—Back pain—Epirubicin—stomach cancer	8.45e-05	0.000433	CcSEcCtD
Lisinopril—Feeling abnormal—Capecitabine—stomach cancer	8.43e-05	0.000432	CcSEcCtD
Lisinopril—Angiopathy—Doxorubicin—stomach cancer	8.42e-05	0.000432	CcSEcCtD
Lisinopril—Malaise—Methotrexate—stomach cancer	8.41e-05	0.000431	CcSEcCtD
Lisinopril—Muscle spasms—Epirubicin—stomach cancer	8.4e-05	0.00043	CcSEcCtD
Lisinopril—Vertigo—Methotrexate—stomach cancer	8.38e-05	0.00043	CcSEcCtD
Lisinopril—Gastrointestinal pain—Capecitabine—stomach cancer	8.36e-05	0.000429	CcSEcCtD
Lisinopril—Mediastinal disorder—Doxorubicin—stomach cancer	8.36e-05	0.000429	CcSEcCtD
Lisinopril—Body temperature increased—Docetaxel—stomach cancer	8.35e-05	0.000428	CcSEcCtD
Lisinopril—Abdominal pain—Docetaxel—stomach cancer	8.35e-05	0.000428	CcSEcCtD
Lisinopril—Leukopenia—Methotrexate—stomach cancer	8.35e-05	0.000428	CcSEcCtD
Lisinopril—Chills—Doxorubicin—stomach cancer	8.33e-05	0.000427	CcSEcCtD
Lisinopril—Arrhythmia—Doxorubicin—stomach cancer	8.29e-05	0.000425	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—stomach cancer	8.28e-05	0.0018	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FST—stomach cancer	8.28e-05	0.0018	CbGpPWpGaD
Lisinopril—Vision blurred—Epirubicin—stomach cancer	8.23e-05	0.000422	CcSEcCtD
Lisinopril—Alopecia—Doxorubicin—stomach cancer	8.2e-05	0.000421	CcSEcCtD
Lisinopril—Cough—Methotrexate—stomach cancer	8.14e-05	0.000418	CcSEcCtD
Lisinopril—Mental disorder—Doxorubicin—stomach cancer	8.13e-05	0.000417	CcSEcCtD
Lisinopril—Urticaria—Capecitabine—stomach cancer	8.13e-05	0.000417	CcSEcCtD
Lisinopril—Ill-defined disorder—Epirubicin—stomach cancer	8.1e-05	0.000415	CcSEcCtD
Lisinopril—Body temperature increased—Capecitabine—stomach cancer	8.09e-05	0.000415	CcSEcCtD
Lisinopril—Abdominal pain—Capecitabine—stomach cancer	8.09e-05	0.000415	CcSEcCtD
Lisinopril—Erythema—Doxorubicin—stomach cancer	8.08e-05	0.000414	CcSEcCtD
Lisinopril—Malnutrition—Doxorubicin—stomach cancer	8.08e-05	0.000414	CcSEcCtD
Lisinopril—Anaemia—Epirubicin—stomach cancer	8.07e-05	0.000414	CcSEcCtD
Lisinopril—Flatulence—Doxorubicin—stomach cancer	7.96e-05	0.000408	CcSEcCtD
Lisinopril—Arthralgia—Methotrexate—stomach cancer	7.94e-05	0.000407	CcSEcCtD
Lisinopril—Chest pain—Methotrexate—stomach cancer	7.94e-05	0.000407	CcSEcCtD
Lisinopril—Myalgia—Methotrexate—stomach cancer	7.94e-05	0.000407	CcSEcCtD
Lisinopril—Tension—Doxorubicin—stomach cancer	7.93e-05	0.000407	CcSEcCtD
Lisinopril—Dysgeusia—Doxorubicin—stomach cancer	7.91e-05	0.000406	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL10—stomach cancer	7.91e-05	0.00171	CbGpPWpGaD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	7.89e-05	0.000405	CcSEcCtD
Lisinopril—Malaise—Epirubicin—stomach cancer	7.87e-05	0.000404	CcSEcCtD
Lisinopril—Discomfort—Methotrexate—stomach cancer	7.85e-05	0.000402	CcSEcCtD
Lisinopril—Nervousness—Doxorubicin—stomach cancer	7.85e-05	0.000402	CcSEcCtD
Lisinopril—Vertigo—Epirubicin—stomach cancer	7.85e-05	0.000402	CcSEcCtD
Lisinopril—Syncope—Epirubicin—stomach cancer	7.83e-05	0.000402	CcSEcCtD
Lisinopril—Leukopenia—Epirubicin—stomach cancer	7.82e-05	0.000401	CcSEcCtD
Lisinopril—Back pain—Doxorubicin—stomach cancer	7.82e-05	0.000401	CcSEcCtD
Lisinopril—Hypersensitivity—Docetaxel—stomach cancer	7.78e-05	0.000399	CcSEcCtD
Lisinopril—Muscle spasms—Doxorubicin—stomach cancer	7.77e-05	0.000398	CcSEcCtD
Lisinopril—Palpitations—Epirubicin—stomach cancer	7.72e-05	0.000396	CcSEcCtD
Lisinopril—Confusional state—Methotrexate—stomach cancer	7.68e-05	0.000394	CcSEcCtD
Lisinopril—Loss of consciousness—Epirubicin—stomach cancer	7.67e-05	0.000394	CcSEcCtD
Lisinopril—Cough—Epirubicin—stomach cancer	7.62e-05	0.000391	CcSEcCtD
Lisinopril—Anaphylactic shock—Methotrexate—stomach cancer	7.62e-05	0.00039	CcSEcCtD
Lisinopril—Vision blurred—Doxorubicin—stomach cancer	7.61e-05	0.00039	CcSEcCtD
Lisinopril—Asthenia—Docetaxel—stomach cancer	7.58e-05	0.000389	CcSEcCtD
Lisinopril—Infection—Methotrexate—stomach cancer	7.57e-05	0.000388	CcSEcCtD
Lisinopril—Hypersensitivity—Capecitabine—stomach cancer	7.54e-05	0.000386	CcSEcCtD
Lisinopril—Ill-defined disorder—Doxorubicin—stomach cancer	7.5e-05	0.000384	CcSEcCtD
Lisinopril—Pruritus—Docetaxel—stomach cancer	7.48e-05	0.000383	CcSEcCtD
Lisinopril—Anaemia—Doxorubicin—stomach cancer	7.47e-05	0.000383	CcSEcCtD
Lisinopril—Thrombocytopenia—Methotrexate—stomach cancer	7.46e-05	0.000382	CcSEcCtD
Lisinopril—Chest pain—Epirubicin—stomach cancer	7.43e-05	0.000381	CcSEcCtD
Lisinopril—Arthralgia—Epirubicin—stomach cancer	7.43e-05	0.000381	CcSEcCtD
Lisinopril—Myalgia—Epirubicin—stomach cancer	7.43e-05	0.000381	CcSEcCtD
Lisinopril—Anxiety—Epirubicin—stomach cancer	7.41e-05	0.00038	CcSEcCtD
Lisinopril—Skin disorder—Methotrexate—stomach cancer	7.4e-05	0.000379	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	7.38e-05	0.000379	CcSEcCtD
Lisinopril—Hyperhidrosis—Methotrexate—stomach cancer	7.36e-05	0.000378	CcSEcCtD
Lisinopril—Discomfort—Epirubicin—stomach cancer	7.34e-05	0.000377	CcSEcCtD
Lisinopril—Asthenia—Capecitabine—stomach cancer	7.34e-05	0.000376	CcSEcCtD
Lisinopril—Malaise—Doxorubicin—stomach cancer	7.29e-05	0.000374	CcSEcCtD
Lisinopril—Dry mouth—Epirubicin—stomach cancer	7.27e-05	0.000373	CcSEcCtD
Lisinopril—Vertigo—Doxorubicin—stomach cancer	7.26e-05	0.000372	CcSEcCtD
Lisinopril—Anorexia—Methotrexate—stomach cancer	7.26e-05	0.000372	CcSEcCtD
Lisinopril—Syncope—Doxorubicin—stomach cancer	7.25e-05	0.000372	CcSEcCtD
Lisinopril—Pruritus—Capecitabine—stomach cancer	7.24e-05	0.000371	CcSEcCtD
Lisinopril—Leukopenia—Doxorubicin—stomach cancer	7.23e-05	0.000371	CcSEcCtD
Lisinopril—Diarrhoea—Docetaxel—stomach cancer	7.23e-05	0.000371	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—stomach cancer	7.23e-05	0.00157	CbGpPWpGaD
Lisinopril—Confusional state—Epirubicin—stomach cancer	7.19e-05	0.000368	CcSEcCtD
Lisinopril—Palpitations—Doxorubicin—stomach cancer	7.14e-05	0.000366	CcSEcCtD
Lisinopril—Anaphylactic shock—Epirubicin—stomach cancer	7.13e-05	0.000365	CcSEcCtD
Lisinopril—Oedema—Epirubicin—stomach cancer	7.13e-05	0.000365	CcSEcCtD
Lisinopril—Hypotension—Methotrexate—stomach cancer	7.12e-05	0.000365	CcSEcCtD
Lisinopril—Loss of consciousness—Doxorubicin—stomach cancer	7.1e-05	0.000364	CcSEcCtD
Lisinopril—Infection—Epirubicin—stomach cancer	7.08e-05	0.000363	CcSEcCtD
Lisinopril—Cough—Doxorubicin—stomach cancer	7.05e-05	0.000362	CcSEcCtD
Lisinopril—Shock—Epirubicin—stomach cancer	7.01e-05	0.00036	CcSEcCtD
Lisinopril—Diarrhoea—Capecitabine—stomach cancer	7e-05	0.000359	CcSEcCtD
Lisinopril—Dizziness—Docetaxel—stomach cancer	6.99e-05	0.000358	CcSEcCtD
Lisinopril—Thrombocytopenia—Epirubicin—stomach cancer	6.98e-05	0.000358	CcSEcCtD
Lisinopril—Tachycardia—Epirubicin—stomach cancer	6.96e-05	0.000357	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Methotrexate—stomach cancer	6.94e-05	0.000356	CcSEcCtD
Lisinopril—Skin disorder—Epirubicin—stomach cancer	6.92e-05	0.000355	CcSEcCtD
Lisinopril—Hyperhidrosis—Epirubicin—stomach cancer	6.89e-05	0.000353	CcSEcCtD
Lisinopril—Insomnia—Methotrexate—stomach cancer	6.89e-05	0.000353	CcSEcCtD
Lisinopril—Arthralgia—Doxorubicin—stomach cancer	6.88e-05	0.000353	CcSEcCtD
Lisinopril—Chest pain—Doxorubicin—stomach cancer	6.88e-05	0.000353	CcSEcCtD
Lisinopril—Myalgia—Doxorubicin—stomach cancer	6.88e-05	0.000353	CcSEcCtD
Lisinopril—Anxiety—Doxorubicin—stomach cancer	6.85e-05	0.000352	CcSEcCtD
Lisinopril—Paraesthesia—Methotrexate—stomach cancer	6.84e-05	0.000351	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	6.83e-05	0.00035	CcSEcCtD
Lisinopril—Discomfort—Doxorubicin—stomach cancer	6.8e-05	0.000348	CcSEcCtD
Lisinopril—Anorexia—Epirubicin—stomach cancer	6.79e-05	0.000348	CcSEcCtD
Lisinopril—Dyspnoea—Methotrexate—stomach cancer	6.79e-05	0.000348	CcSEcCtD
Lisinopril—Somnolence—Methotrexate—stomach cancer	6.77e-05	0.000347	CcSEcCtD
Lisinopril—Dizziness—Capecitabine—stomach cancer	6.76e-05	0.000347	CcSEcCtD
Lisinopril—Dry mouth—Doxorubicin—stomach cancer	6.73e-05	0.000345	CcSEcCtD
Lisinopril—Vomiting—Docetaxel—stomach cancer	6.72e-05	0.000344	CcSEcCtD
Lisinopril—Dyspepsia—Methotrexate—stomach cancer	6.7e-05	0.000344	CcSEcCtD
Lisinopril—Rash—Docetaxel—stomach cancer	6.66e-05	0.000342	CcSEcCtD
Lisinopril—Hypotension—Epirubicin—stomach cancer	6.66e-05	0.000341	CcSEcCtD
Lisinopril—Dermatitis—Docetaxel—stomach cancer	6.66e-05	0.000341	CcSEcCtD
Lisinopril—Confusional state—Doxorubicin—stomach cancer	6.65e-05	0.000341	CcSEcCtD
Lisinopril—Decreased appetite—Methotrexate—stomach cancer	6.62e-05	0.000339	CcSEcCtD
Lisinopril—Headache—Docetaxel—stomach cancer	6.62e-05	0.000339	CcSEcCtD
Lisinopril—Anaphylactic shock—Doxorubicin—stomach cancer	6.59e-05	0.000338	CcSEcCtD
Lisinopril—Oedema—Doxorubicin—stomach cancer	6.59e-05	0.000338	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Methotrexate—stomach cancer	6.57e-05	0.000337	CcSEcCtD
Lisinopril—Fatigue—Methotrexate—stomach cancer	6.57e-05	0.000337	CcSEcCtD
Lisinopril—Infection—Doxorubicin—stomach cancer	6.55e-05	0.000336	CcSEcCtD
Lisinopril—Pain—Methotrexate—stomach cancer	6.51e-05	0.000334	CcSEcCtD
Lisinopril—Vomiting—Capecitabine—stomach cancer	6.5e-05	0.000334	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Epirubicin—stomach cancer	6.49e-05	0.000333	CcSEcCtD
Lisinopril—Shock—Doxorubicin—stomach cancer	6.49e-05	0.000333	CcSEcCtD
Lisinopril—Thrombocytopenia—Doxorubicin—stomach cancer	6.46e-05	0.000331	CcSEcCtD
Lisinopril—Rash—Capecitabine—stomach cancer	6.45e-05	0.000331	CcSEcCtD
Lisinopril—Insomnia—Epirubicin—stomach cancer	6.45e-05	0.000331	CcSEcCtD
Lisinopril—Dermatitis—Capecitabine—stomach cancer	6.44e-05	0.00033	CcSEcCtD
Lisinopril—Tachycardia—Doxorubicin—stomach cancer	6.44e-05	0.00033	CcSEcCtD
Lisinopril—Headache—Capecitabine—stomach cancer	6.41e-05	0.000329	CcSEcCtD
Lisinopril—Skin disorder—Doxorubicin—stomach cancer	6.4e-05	0.000328	CcSEcCtD
Lisinopril—Paraesthesia—Epirubicin—stomach cancer	6.4e-05	0.000328	CcSEcCtD
Lisinopril—Hyperhidrosis—Doxorubicin—stomach cancer	6.37e-05	0.000327	CcSEcCtD
Lisinopril—Dyspnoea—Epirubicin—stomach cancer	6.35e-05	0.000326	CcSEcCtD
Lisinopril—Somnolence—Epirubicin—stomach cancer	6.34e-05	0.000325	CcSEcCtD
Lisinopril—Anorexia—Doxorubicin—stomach cancer	6.29e-05	0.000322	CcSEcCtD
Lisinopril—Nausea—Docetaxel—stomach cancer	6.28e-05	0.000322	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	6.28e-05	0.00136	CbGpPWpGaD
Lisinopril—Feeling abnormal—Methotrexate—stomach cancer	6.28e-05	0.000322	CcSEcCtD
Lisinopril—Dyspepsia—Epirubicin—stomach cancer	6.27e-05	0.000322	CcSEcCtD
Lisinopril—Gastrointestinal pain—Methotrexate—stomach cancer	6.23e-05	0.000319	CcSEcCtD
Lisinopril—Decreased appetite—Epirubicin—stomach cancer	6.19e-05	0.000318	CcSEcCtD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—stomach cancer	6.19e-05	0.00134	CbGpPWpGaD
Lisinopril—Hypotension—Doxorubicin—stomach cancer	6.16e-05	0.000316	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Epirubicin—stomach cancer	6.15e-05	0.000315	CcSEcCtD
Lisinopril—Fatigue—Epirubicin—stomach cancer	6.14e-05	0.000315	CcSEcCtD
Lisinopril—Pain—Epirubicin—stomach cancer	6.09e-05	0.000313	CcSEcCtD
Lisinopril—Constipation—Epirubicin—stomach cancer	6.09e-05	0.000313	CcSEcCtD
Lisinopril—Nausea—Capecitabine—stomach cancer	6.08e-05	0.000312	CcSEcCtD
Lisinopril—Urticaria—Methotrexate—stomach cancer	6.05e-05	0.00031	CcSEcCtD
Lisinopril—Abdominal pain—Methotrexate—stomach cancer	6.02e-05	0.000309	CcSEcCtD
Lisinopril—Body temperature increased—Methotrexate—stomach cancer	6.02e-05	0.000309	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Doxorubicin—stomach cancer	6.01e-05	0.000308	CcSEcCtD
Lisinopril—Insomnia—Doxorubicin—stomach cancer	5.96e-05	0.000306	CcSEcCtD
Lisinopril—Paraesthesia—Doxorubicin—stomach cancer	5.92e-05	0.000304	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—stomach cancer	5.89e-05	0.00128	CbGpPWpGaD
Lisinopril—Dyspnoea—Doxorubicin—stomach cancer	5.88e-05	0.000301	CcSEcCtD
Lisinopril—Feeling abnormal—Epirubicin—stomach cancer	5.87e-05	0.000301	CcSEcCtD
Lisinopril—Somnolence—Doxorubicin—stomach cancer	5.86e-05	0.000301	CcSEcCtD
Lisinopril—Gastrointestinal pain—Epirubicin—stomach cancer	5.83e-05	0.000299	CcSEcCtD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—ALB—stomach cancer	5.81e-05	0.00126	CbGpPWpGaD
Lisinopril—Dyspepsia—Doxorubicin—stomach cancer	5.8e-05	0.000298	CcSEcCtD
Lisinopril—Decreased appetite—Doxorubicin—stomach cancer	5.73e-05	0.000294	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Doxorubicin—stomach cancer	5.69e-05	0.000292	CcSEcCtD
Lisinopril—Fatigue—Doxorubicin—stomach cancer	5.68e-05	0.000292	CcSEcCtD
Lisinopril—Urticaria—Epirubicin—stomach cancer	5.66e-05	0.00029	CcSEcCtD
Lisinopril—Constipation—Doxorubicin—stomach cancer	5.64e-05	0.000289	CcSEcCtD
Lisinopril—Pain—Doxorubicin—stomach cancer	5.64e-05	0.000289	CcSEcCtD
Lisinopril—Abdominal pain—Epirubicin—stomach cancer	5.63e-05	0.000289	CcSEcCtD
Lisinopril—Body temperature increased—Epirubicin—stomach cancer	5.63e-05	0.000289	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	5.63e-05	0.00122	CbGpPWpGaD
Lisinopril—Hypersensitivity—Methotrexate—stomach cancer	5.61e-05	0.000288	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CASP8—stomach cancer	5.47e-05	0.00119	CbGpPWpGaD
Lisinopril—Asthenia—Methotrexate—stomach cancer	5.46e-05	0.00028	CcSEcCtD
Lisinopril—Feeling abnormal—Doxorubicin—stomach cancer	5.43e-05	0.000279	CcSEcCtD
Lisinopril—Gastrointestinal pain—Doxorubicin—stomach cancer	5.39e-05	0.000276	CcSEcCtD
Lisinopril—Pruritus—Methotrexate—stomach cancer	5.39e-05	0.000276	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	5.36e-05	0.00116	CbGpPWpGaD
Lisinopril—Hypersensitivity—Epirubicin—stomach cancer	5.25e-05	0.000269	CcSEcCtD
Lisinopril—Urticaria—Doxorubicin—stomach cancer	5.24e-05	0.000269	CcSEcCtD
Lisinopril—Body temperature increased—Doxorubicin—stomach cancer	5.21e-05	0.000267	CcSEcCtD
Lisinopril—Abdominal pain—Doxorubicin—stomach cancer	5.21e-05	0.000267	CcSEcCtD
Lisinopril—Diarrhoea—Methotrexate—stomach cancer	5.21e-05	0.000267	CcSEcCtD
Lisinopril—Asthenia—Epirubicin—stomach cancer	5.11e-05	0.000262	CcSEcCtD
Lisinopril—Pruritus—Epirubicin—stomach cancer	5.04e-05	0.000259	CcSEcCtD
Lisinopril—Dizziness—Methotrexate—stomach cancer	5.04e-05	0.000258	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—HMOX1—stomach cancer	4.92e-05	0.00107	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	4.9e-05	0.00106	CbGpPWpGaD
Lisinopril—Diarrhoea—Epirubicin—stomach cancer	4.88e-05	0.00025	CcSEcCtD
Lisinopril—Hypersensitivity—Doxorubicin—stomach cancer	4.86e-05	0.000249	CcSEcCtD
Lisinopril—Vomiting—Methotrexate—stomach cancer	4.84e-05	0.000248	CcSEcCtD
Lisinopril—Rash—Methotrexate—stomach cancer	4.8e-05	0.000246	CcSEcCtD
Lisinopril—Dermatitis—Methotrexate—stomach cancer	4.8e-05	0.000246	CcSEcCtD
Lisinopril—Headache—Methotrexate—stomach cancer	4.77e-05	0.000245	CcSEcCtD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—stomach cancer	4.73e-05	0.00103	CbGpPWpGaD
Lisinopril—Asthenia—Doxorubicin—stomach cancer	4.73e-05	0.000243	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—MMP2—stomach cancer	4.73e-05	0.00103	CbGpPWpGaD
Lisinopril—Dizziness—Epirubicin—stomach cancer	4.71e-05	0.000242	CcSEcCtD
Lisinopril—Pruritus—Doxorubicin—stomach cancer	4.67e-05	0.000239	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—JUN—stomach cancer	4.64e-05	0.00101	CbGpPWpGaD
Lisinopril—Vomiting—Epirubicin—stomach cancer	4.53e-05	0.000232	CcSEcCtD
Lisinopril—Nausea—Methotrexate—stomach cancer	4.52e-05	0.000232	CcSEcCtD
Lisinopril—Diarrhoea—Doxorubicin—stomach cancer	4.51e-05	0.000231	CcSEcCtD
Lisinopril—Rash—Epirubicin—stomach cancer	4.49e-05	0.00023	CcSEcCtD
Lisinopril—Dermatitis—Epirubicin—stomach cancer	4.49e-05	0.00023	CcSEcCtD
Lisinopril—Headache—Epirubicin—stomach cancer	4.46e-05	0.000229	CcSEcCtD
Lisinopril—Dizziness—Doxorubicin—stomach cancer	4.36e-05	0.000224	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CXCL8—stomach cancer	4.32e-05	0.000937	CbGpPWpGaD
Lisinopril—Nausea—Epirubicin—stomach cancer	4.23e-05	0.000217	CcSEcCtD
Lisinopril—Vomiting—Doxorubicin—stomach cancer	4.19e-05	0.000215	CcSEcCtD
Lisinopril—Rash—Doxorubicin—stomach cancer	4.16e-05	0.000213	CcSEcCtD
Lisinopril—Dermatitis—Doxorubicin—stomach cancer	4.15e-05	0.000213	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL1B—stomach cancer	4.15e-05	0.000899	CbGpPWpGaD
Lisinopril—Headache—Doxorubicin—stomach cancer	4.13e-05	0.000212	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	4.09e-05	0.000886	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—stomach cancer	4.05e-05	0.000879	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	4.02e-05	0.000872	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ACAD8—stomach cancer	3.97e-05	0.000861	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	3.95e-05	0.000856	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CXCL8—stomach cancer	3.93e-05	0.000852	CbGpPWpGaD
Lisinopril—Nausea—Doxorubicin—stomach cancer	3.92e-05	0.000201	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—APOA1—stomach cancer	3.73e-05	0.000808	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	3.69e-05	0.0008	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GMPR2—stomach cancer	3.54e-05	0.000767	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—VEGFA—stomach cancer	3.51e-05	0.000761	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—IDH3B—stomach cancer	3.24e-05	0.000702	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SUCLG1—stomach cancer	3.24e-05	0.000702	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	3.08e-05	0.000667	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TNF—stomach cancer	3.01e-05	0.000653	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NDUFV1—stomach cancer	3.01e-05	0.000652	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NDUFS1—stomach cancer	3.01e-05	0.000652	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ALB—stomach cancer	2.95e-05	0.00064	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	2.9e-05	0.000628	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	2.7e-05	0.000585	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PGLS—stomach cancer	2.68e-05	0.000581	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—BLVRB—stomach cancer	2.68e-05	0.000581	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPAP2A—stomach cancer	2.56e-05	0.000555	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CA1—stomach cancer	2.28e-05	0.000494	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—FBP1—stomach cancer	2.28e-05	0.000494	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NDUFA2—stomach cancer	2.28e-05	0.000494	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CKB—stomach cancer	2.28e-05	0.000494	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	2.25e-05	0.000488	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	2.2e-05	0.000477	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PLIN2—stomach cancer	2.14e-05	0.000465	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CA2—stomach cancer	2.09e-05	0.000452	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	2.08e-05	0.000452	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PGAM1—stomach cancer	2.03e-05	0.000441	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NT5E—stomach cancer	2.03e-05	0.000441	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	1.99e-05	0.000431	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	1.98e-05	0.00043	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PLCE1—stomach cancer	1.94e-05	0.00042	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALDH7A1—stomach cancer	1.94e-05	0.00042	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	1.92e-05	0.000417	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	1.88e-05	0.000407	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—UMPS—stomach cancer	1.86e-05	0.000403	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	1.73e-05	0.000376	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PDHA1—stomach cancer	1.73e-05	0.000375	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ECHS1—stomach cancer	1.73e-05	0.000375	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.66e-05	0.000361	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.64e-05	0.000355	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TYMP—stomach cancer	1.62e-05	0.000352	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—FADS1—stomach cancer	1.62e-05	0.000352	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.59e-05	0.000346	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.56e-05	0.000338	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.56e-05	0.000338	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SREBF2—stomach cancer	1.52e-05	0.00033	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—RORA—stomach cancer	1.5e-05	0.000326	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.48e-05	0.000322	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.47e-05	0.000319	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALDOB—stomach cancer	1.41e-05	0.000305	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.35e-05	0.000293	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALOX5—stomach cancer	1.31e-05	0.000284	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.31e-05	0.000284	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—DPYD—stomach cancer	1.29e-05	0.000279	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.26e-05	0.000273	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTT1—stomach cancer	1.14e-05	0.000247	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP2A6—stomach cancer	1.13e-05	0.000244	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AKR1C3—stomach cancer	1.1e-05	0.000238	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ENO1—stomach cancer	1.07e-05	0.000231	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	9.98e-06	0.000216	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CD44—stomach cancer	9.47e-06	0.000205	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPP2R1A—stomach cancer	8.05e-06	0.000175	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTP1—stomach cancer	7.9e-06	0.000171	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HMOX1—stomach cancer	7.79e-06	0.000169	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TYMS—stomach cancer	7.34e-06	0.000159	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTM1—stomach cancer	7.26e-06	0.000157	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ERCC2—stomach cancer	6.82e-06	0.000148	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MTHFR—stomach cancer	6.41e-06	0.000139	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CAV1—stomach cancer	5.91e-06	0.000128	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOA1—stomach cancer	5.9e-06	0.000128	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARG—stomach cancer	5.2e-06	0.000113	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALB—stomach cancer	4.68e-06	0.000101	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NOS3—stomach cancer	4.47e-06	9.7e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTGS2—stomach cancer	4.09e-06	8.87e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CA—stomach cancer	2.52e-06	5.46e-05	CbGpPWpGaD
